Astrazeneca Share Discussion Threads

[ayl30] 09/11/2020 05:02

Australia productionhttps://www.thetimes.co.uk/article/australian-lab-to-start-producing-oxford-covid-19-vaccine-z7whg0hwz?shareToken=ad9ecf3a24fd5c104c589276e0907627

[buywell3] 08/11/2020 07:16

Cost implications possible for some imo

[brummy_git] 06/11/2020 16:05

AZN mentioned here

hxxps://www.linkedin.com/posts/paul-hill-a5994116_justin-waite-paul-hill-talk-about-7-stocks-activity-6730489344181768192-vA_g

[gateside] 06/11/2020 07:15

Further positive news released from AZN - they have an excellent pipeline of drugs

[alphorn] 05/11/2020 14:55

The above ties with this answer - The Oxford team, working with pharmaceutical firm AstraZeneca, has not yet looked at any results to find out whether it works and will protect people against the virus or prevent them becoming seriously ill. “I’m optimistic that we could reach that point before the end of this year to do an analysis,” he said. But then they would need to put their data to the regulatory authorities.

If this is the position then Oxford is talking about presenting the data only at the end of year. .........it will then need to be reviewed and approved.

This would answer my question re UK v EMA post 01/01/21.

[alphorn] 05/11/2020 12:17

Some good approvals in today's Q3 notes.

Unless I am reading the notes differently progress on the vaccine is very factual (as you would expect) and not reading as the UK media is reporting as 'imminent'.

[jimarilo] 05/11/2020 09:52

Big Pharma whistle blower.......there is no covid virus

MP's & msm involved in mass fraud

[bogman1] 30/10/2020 11:08

Accelerated uk review for Astra and pfizer vaccines

[badtime] 30/10/2020 10:36

Or focus on another BB

[alphorn] 30/10/2020 08:48

"vaccine failures"

You obviously do not understand the industry. Risk/reward - the failure rate is high. It is always a challenge to motivate the R&D teams so that successes are celebrated but shelved projects do not penalise their teams.

Perhaps you should focus on other industries.

[buywell3] 30/10/2020 08:12

buywell is of the opinion that the cost of vaccine failures is going to cost some Governments and some BIG Pharma Co's $ Billions

Vaccines are NOT in buywells opinion the panacea of investment now

Next year will determine if buywell was correct or not

dyor

[dudishes] 28/10/2020 04:19

bogman1, remembering that all are in together for the first year.

[bogman1] 26/10/2020 12:33

Just added today, top pick of Berenberg and JP. Should be a vaccine shortly, leaked nhs mail indicates it could be British imho.

[our haven] 26/10/2020 12:08

Test results for Covid vaccine in the over 56 looks very promising and interesting to see what impact that news has on the price.

[alphorn] 24/10/2020 13:19

No probs. It is an area badly understood, hence my post on #882. It is one hell of an incentive for AZN to get a full EMA submission in the next 2 months.

[gregb] 24/10/2020 11:49

I stand corrected Alphorn. Please accept my apologies.

[alphorn] 24/10/2020 11:03

GB - the EMA has relocated out of London. It means multiple approvals which were not required in the past. ie more work and potentially more time.

"The European Medicines Agency is an agency of the European Union"

[gregb] 24/10/2020 11:01

Doesn't stop AZN applying for EMA approval. The UK has left the European Union, not Europe.

[alphorn] 24/10/2020 10:40

Nobody has pointed out this fact yet; that from 01/01/21, as we stand, the UK is no longer part of the EMA regarding approvals.
(Note. please do not take this as anti AZN as it covers all pharmas).